We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current IMUC market cap is 17.78M. The company's latest EPS is USD -0.0142 and P/E is -11.27.
| Year End 31 December 2023 | 2017 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.15M | -535k | -2.61M | -2.89M | -1.82M |
| Net Income | -17.68M | -535k | -2.68M | -2.65M | -1.61M |
| Year End 31 December 2023 | 2017 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.01M | 1.67M | 1.67M | 769k | 409k |
| Total Liabilities | 2.36M | 35k | 1.84M | 4.96M | 6.1M |
| Total Equity | 4.65M | 1.64M | -172k | -4.19M | -5.69M |
| Year End 31 December 2023 | 2017 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.67M | -508k | -2.31M | -2.62M | -1.42M |
| Investing | 1,000 | N/A | N/A | N/A | N/A |
| Financing | 11.86M | -50k | 3.53M | 1.75M | 1.09M |
| Market Cap | 17.78M |
| Price to Earnings Ratio | -11.27 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 64 |
| Price to Book Ratio | -3.18 |
| Dividend Yield | - |
| Shares Outstanding | 113.27M |
| Average Volume (1 week) | 12.16k |
| Average Volume (1 Month) | 5.52k |
| 52 Week Change | -37.20% |
| 52 Week High | 0.30 |
| 52 Week Low | 0.0123 |
| Spread (Intraday) | 0.15 (93.63%) |
| Company Name | EOM Pharmaceutical Holdings Inc (PK) |
| Address |
1209 orange st wilmington, delaware 19801 |
| Website | https://www.eompharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
